AstraZeneca’s is one of several companies given emergency authorization of use
TDS News – Following Health Canada’s authorization of the AstraZeneca COVID-19 vaccine, Anita Anand, Minister of Public Services and Procurement, announced today that Canada has secured 2 million doses of the AstraZeneca COVID-19 vaccine through an agreement with Verity Pharmaceuticals Canada Inc./Serum Institute of India.
“The Government of Canada continues to do everything possible to protect Canadians from COVID-19. We remain fully on track to ensure that there will be a sufficient supply so that every eligible Canadian who wants a vaccine will have access to one by the end of September.” Anita Anand Minister of Public Services and Procurement
AstraZeneca has licensed the manufacture of its COVID-19 vaccine to the Serum Institute. The first 500,000 doses will be delivered to Canada in the coming weeks and will quickly be ready for distribution to the provinces and territories. The remaining 1.5 million doses will arrive by mid-May.
The 2 million doses secured through this agreement are in addition to the 20 million doses already secured through an earlier agreement with AstraZeneca. Health Canada’s authorization of the AstraZeneca vaccine allows the Government of Canada to advance its work with AstraZeneca to finalize delivery schedules for the 20 million doses.
Canada has an ambitious plan to vaccine all Canadians by September 2021.